China, Sept. 11 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A clinical study to evaluate the safety, tolerability, biodistribution, radiation dosimetry, and preliminary diagnostic efficacy of 68Ga-BIBD-492 in patients with malignant tumors.'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600132236
Registration Time: 2026/09/10
Type: Interventional study
Primary Sponsor: Tianjin Medical University Cancer Institute and Hospital
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=339515
Published by HT Digital Content Services with permission from Health Daily Digest....